DCF — ADVENTHEALTH WATERMAN
Enterprise Value: $-319.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-319.0M
Enterprise Value
$-105.9M
PV of Cash Flows
$-213.0M
PV of Terminal Value
$-343.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $348.9M | $-17.1M | -5.0% | $-31.9M | $-29.0M |
| Year 2 | $359.3M | $-14.1M | -4.0% | $-29.3M | $-24.2M |
| Year 3 | $370.1M | $-10.8M | -3.0% | $-26.4M | $-19.9M |
| Year 4 | $381.2M | $-9.2M | -2.0% | $-25.3M | $-17.3M |
| Year 5 | $392.7M | $-8.5M | -2.0% | $-25.1M | $-15.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-319.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$338.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.054102930327974544
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5